Very early researchUnknownNCT04156269What this trial is testingBCMA-CS1 Compound CAR (cCAR) T Cells for Relapsed/Refractory Multiple MyelomaWho this might be right forMultiple Myeloma iCell Gene Therapeutics 12
Not applicableUnknownNCT03498105What this trial is testingUtility of the Cardiac Electrical BiomarkerDiseaseWho this might be right forAcute Chest Syndrome Joanne Turner 800
Testing effectiveness (Phase 2)Looking for participantsNCT06566742What this trial is testingStudy Evaluating Olutasidenib in Patients With IDH1-mutated Clonal Cytopenia of Undetermined Significance and Lower-risk Myelodysplastic/Syndromes/Chronic Myelomonocytic Leukemia.Who this might be right forMyelodysplastic SyndromesChronic Myelomonocytic LeukemiaClonal Cytopenia of Undetermined Significance M.D. Anderson Cancer Center 15
Large-scale testing (Phase 3)Study completedNCT02140242What this trial is testingComparison Between Two Dose Levels of Daunorubicin and Between One vs. Two Induction Cycles for Adult Patients With AMLWho this might be right forLeukemia, Myelocytic, Acute Technische Universität Dresden 721
Testing effectiveness (Phase 2)Looking for participantsNCT06015542What this trial is testingSelf-administration of Subcutaneous Elranatamab in the Patients' Homes.Who this might be right forMultiple Myeloma Thomas Lund 20
Early research (Phase 1)Study completedNCT02270788What this trial is testingCrenolanib in Combination With Sorafenib in Patients With Refractory or Relapsed Hematologic MalignanciesWho this might be right forAcute Myeloid Leukemia St. Jude Children's Research Hospital 10
Not applicableUnknownNCT03868527What this trial is testingThe ARCAN Database is Used for Retrospective Non-interventional Research Projects. The Database Collects Clinical and Laboratory Data From Patients With Lymphoid Malignancies. The Database Doesn't Require Biological Sample of Patients, it Records Only Information Based on the Patients' Medical File.Who this might be right forHematologic Diseases Hospices Civils de Lyon 13,000
Not applicableStudy completedNCT04309942What this trial is testingEvaluation Study on Performance of Guided Clinical Pharmacy Consultation in Patients With Multiple Myeloma on First Oral Anticancer TreatmentWho this might be right forMultiple Myeloma Centre Hospitalier Universitaire de Nīmes 60
Early research (Phase 1)UnknownNCT01280786What this trial is testingStudy Elesclomol Sodium in Patients With Relapsed or Refractory Acute Myeloid LeukemiaWho this might be right forAcute Myeloid Leukemia Synta Pharmaceuticals Corp. 36
Not applicableUnknownNCT04515420What this trial is testingThe Influence of Noradrenaline on Coagulation and Fibrinolysis in Severe Isolated Brain InjuryWho this might be right forBrain Injuries, TraumaticCoagulopathyCoagulation Defect; Acquired+2 more University Medical Centre Ljubljana 60
Testing effectiveness (Phase 2)Study completedNCT03318159What this trial is testingPosaconazole Prophylaxis During ATG Treatment for hMDS/AA PatientsWho this might be right forAplastic AnemiaMyelodysplastic SyndromesFungal Infection Seoul National University Hospital 20
Not applicableEnded earlyNCT02755480What this trial is testingUltralow Dose Thoracic Computed Tomography in Immunocompromised PatientsWho this might be right forLeukemia University Health Network, Toronto 119
Early research (Phase 1)Study completedNCT00275080What this trial is testingVorinostat and Decitabine in Treating Patients With Advanced Solid Tumors or Relapsed or Refractory Non-Hodgkin's Lymphoma, Acute Myeloid Leukemia, Acute Lymphocytic Leukemia, or Chronic Myelogenous LeukemiaWho this might be right forAdult Acute Myeloid Leukemia With 11q23 (MLL) AbnormalitiesAdult Acute Myeloid Leukemia With Inv(16)(p13;q22)Adult Acute Myeloid Leukemia With t(15;17)(q22;q12)+48 more National Cancer Institute (NCI) 80
Not applicableActive Not RecruitingNCT07413679What this trial is testingLong-term Safety of Danicopan: IPIG Registry-based Cohort StudyWho this might be right forParoxysmal Nocturnal HemoglobinuriaPNH Alexion Pharmaceuticals, Inc. 50
Testing effectiveness (Phase 2)Study completedNCT01529827What this trial is testingFludarabine Phosphate, Melphalan, and Low-Dose Total-Body Irradiation Followed by Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic MalignanciesWho this might be right forAccelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in Remission+75 more Roswell Park Cancer Institute 94
Testing effectiveness (Phase 2)UnknownNCT01417169What this trial is testingMicafungin Prevention Study for Invasive Fungal Disease in Pediatric & Adolescent Patients Undergoing Autologous Hematopoietic Stem Cell TransplantationWho this might be right forNeutropeniaFungal Disease Seoul National University Hospital 112
Large-scale testing (Phase 3)Looking for participantsNCT05156983What this trial is testingTAK-330 to Reverse the Effects of Factor Xa Inhibitors For Adults Needing Urgent SurgeryWho this might be right forCoagulation Disorder Takeda 440
Not applicableUnknownNCT04727294What this trial is testingMGUS, SMM, and MM Patient Experience With Coronavirus 19 (COVID-19) SurveyWho this might be right forMultiple MyelomaSmoldering Multiple MyelomaMonoclonal Gammopathy of Undetermined Significance+1 more HealthTree Foundation 1,500
Testing effectiveness (Phase 2)Ended earlyNCT02353572What this trial is testingMelphalan and Bortezomib Prior to Autologous Stem Cell Transplant in Treating Patients With Multiple MyelomaWho this might be right forPlasma Cell MyelomaPlasmacytosisRecurrent Plasma Cell Myeloma+1 more University of Colorado, Denver 3
Testing effectiveness (Phase 2)Study completedNCT00482495What this trial is testingBevacizumab in Treating Patients With Relapsed or Refractory Multiple MyelomaWho this might be right forMultiple Myeloma and Plasma Cell Neoplasm Mayo Clinic 42